五洲医疗(301234) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥130,464,600.01, a decrease of 5.48% compared to ¥138,023,356.31 in the same period last year[3] - Net profit attributable to shareholders for Q3 2024 was ¥12,567,859.00, down 29.59% from ¥17,848,470.34 in the previous year[3] - The net profit excluding non-recurring gains and losses was ¥8,997,575.84, reflecting a significant decline of 48.86% from ¥17,371,450.36 in the same period last year[3] - The basic earnings per share for Q3 2024 was ¥0.1848, a decrease of 29.60% compared to ¥0.2625 in the previous year[3] - Operating profit for Q3 2024 was ¥40,874,703.36, down 37.0% from ¥64,872,348.79 in the same period last year[17] - Net profit for Q3 2024 was ¥34,335,329.36, a decline of 36.5% compared to ¥54,046,043.52 in Q3 2023[17] - Basic earnings per share for Q3 2024 were ¥0.5049, down from ¥0.7948 in the same quarter last year, reflecting a decrease of 36.5%[17] - The company reported a total comprehensive income of ¥34,335,329.36 for Q3 2024, consistent with the net profit figure[17] Assets and Liabilities - The total assets at the end of the reporting period were ¥858,770,848.93, representing a 1.25% increase from ¥848,178,419.23 at the end of the previous year[3] - Total assets increased to ¥858,770,848.93 in Q3 2024 from ¥848,178,419.23 in Q3 2023, reflecting a growth of 0.7%[15] - Total liabilities rose to ¥101,908,940.55, up from ¥98,470,621.61, marking an increase of 2.9% year-over-year[15] - The company's cash and cash equivalents were not detailed, but the total non-current assets decreased to ¥326,656,891.87 from ¥340,452,064.18, a decline of 4.0%[15] - Accounts payable increased to ¥67,805,835.23 from ¥60,481,515.81, representing an increase of 12.1% year-over-year[15] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥73,855,724.26, an increase of 42.67% compared to ¥51,765,882.97 in the previous year[3] - The total cash inflow from operating activities for the current period was ¥388,865,505.03, a decrease of 14.4% compared to ¥454,443,205.55 in the previous period[19] - The net cash flow from operating activities increased to ¥73,855,724.26, up 42.6% from ¥51,765,882.97 in the previous period[19] - Cash inflow from investment activities totaled ¥628,890,104.22, compared to ¥593,168,161.45 in the previous period, marking an increase of 6.0%[19] - The net cash flow from investment activities was -¥149,593,661.13, a significant decline from ¥161,729,822.90 in the previous period[19] - Cash outflow from financing activities was ¥27,381,218.60, down from ¥34,617,859.20 in the previous period, reflecting a decrease of 20.0%[20] - The net increase in cash and cash equivalents was -¥100,131,370.08, compared to an increase of ¥180,650,408.76 in the previous period[20] - The ending balance of cash and cash equivalents was ¥167,991,874.58, down from ¥282,937,575.99 in the previous period[20] Income and Expenses - The company reported a significant increase in other income, which rose by 356.34% to ¥8,354,861.38 due to increased government subsidies[8] - The company experienced a 31.74% increase in tax and additional charges, amounting to ¥2,454,713.65, primarily due to increased property tax[8] - The company’s financial expenses decreased by 31.02% to -¥5,118,936.73, attributed to reduced exchange rate losses[8] - Cash received from operating activities increased by 118.93% to ¥13,358,360.57, primarily due to an increase in government subsidies received[9] - Taxes paid decreased by 52.22% to ¥5,637,178.09, mainly due to a reduction in prepaid corporate income tax[9] - Cash paid for the purchase of fixed assets, intangible assets, and other long-term assets decreased by 50.85% to ¥26,483,765.35, attributed to a decrease in fixed asset payments[9] - The cash paid for purchasing goods and services was ¥234,553,544.52, a decrease of 24.8% from ¥311,771,823.35 in the previous period[19] - The company reported a cash inflow from tax refunds of ¥34,612,482.86, down from ¥43,509,970.42 in the previous period, a decrease of 20.5%[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 7,533, with the top ten shareholders holding a combined 70.65% of shares[10] Investment Activities - Investment cash payments doubled to ¥752,000,000.00, primarily due to an increase in the amount spent on purchasing financial products[9] - Trading financial assets increased significantly to ¥200,306,844.94 from ¥75,244,194.34, showing a strategic shift towards financial investments[13] - Accounts receivable rose to ¥96,939,664.54 from ¥92,696,934.48, indicating an increase in sales on credit[13] - Fixed assets slightly increased to ¥305,395,434.35 from ¥304,661,292.44, reflecting stable investment in physical assets[13]